Indometacínový Vulm (Indometacin)

Indometacin blocks the cyclooxygenase enzymes COX‑1 and COX‑2, which are essential for producing prostaglandins—molecules that promote inflammation, pain, and fever. By lowering prostaglandin levels at the site of application, indometacin diminishes the inflammatory response and provides analgesia.

The specific dose and frequency of application are determined by the prescribing healthcare professional based on the severity of the condition, the size of the treatment area, and patient factors. Patients should follow the prescriber’s instructions and the product label.

Safety data for topical indometacin in pregnancy and lactation are limited. Healthcare providers generally weigh the potential benefits against possible risks before prescribing. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternative options with their clinician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Indometacínový Vulm contains indometacin, which is a potent COX inhibitor and may provide stronger anti‑inflammatory effects than some other topical NSAIDs such as diclofenac or ibuprofen. Choice of product depends on the clinician’s assessment of efficacy, tolerability, and patient‑specific factors.

Store the product at room temperature, preferably below 25 °C. Keep it in the original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

The gel or cream is applied to clean, dry skin over the affected area. A thin layer is spread gently and massaged until absorbed. The frequency and duration of use are set by the prescriber, typically ranging from once to several times daily.

Serious risks include severe allergic reactions such as anaphylaxis, life‑threatening skin conditions like Stevens‑Johnson syndrome or toxic epidermal necrolysis, and systemic toxicity affecting liver or kidneys. Patients should seek immediate medical attention if they notice extensive rash, blistering, or systemic symptoms.

Individuals with known hypersensitivity to indometacin or any component of the formulation should avoid use. Patients with active gastrointestinal ulcers, severe renal or hepatic impairment, uncontrolled cardiovascular disease, or those taking interacting medications (e.g., anticoagulants, methotrexate, lithium) should consult their healthcare provider before use.